Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib

Drug Development and Industrial Pharmacy

Volumn 41, Issue 1, 2015, Pages 95-104

  Bilthariya, Upasana ^a   Jain, Nivrati ^a   Rajoriya, Vaibhav ^a   Jain, Ashish Kumar ^a  

^a ADINA Institute of Pharmaceutical Sciences   (India)

Author keywords

Activated macrophages targeting; Etoricoxib; Folate conjugation; Inflammation screening; Rheumatoid arthritis

Indexed keywords

ALBUMIN CONJUGATE; BOVINE SERUM ALBUMIN; ETORICOXIB; FOLATE RECEPTOR; FOLIC ACID; NANOPARTICLE; PYRIDINE DERIVATIVE; SULFONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG TARGETING; INFRARED SPECTROSCOPY; MACROPHAGE; MALE; MOUSE; NANOENCAPSULATION; NONHUMAN; RAT; RHEUMATOID ARTHRITIS; ZETA POTENTIAL; ANIMAL; ARTHRITIS, RHEUMATOID; BAGG ALBINO MOUSE; BOVINE; CHEMISTRY; PATHOLOGY; PROCEDURES;

ANIMALS; ARTHRITIS, RHEUMATOID; CATTLE; DRUG DELIVERY SYSTEMS; FOLIC ACID; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; PYRIDINES; SERUM ALBUMIN, BOVINE; SULFONES;

EID: 84918775123     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.850705     Document Type: Article

References (28)

1. Turk MJ, Breur Gert J, Low PS, Paulos CM. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 2004;56: 1205-17.
2. Kinne RW, Brauer R, Stuhlmuller B, et al. Macrophages in rheumatoid arthritis. Arthritis Res 2000;2:189-202.
3. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994;53:39-44.
4. Tak PP, Smeets TJ, Daha RR, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997;40:217-25.
5. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996;39:115-24.
6. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001;161:1-15.
7. Salter DN, Scott KJ, Slade H, Andrews P. The preparation and properties of folate-binding protein from cow's milk. Biochem J 1981;193:469-76.
8. Selhub J, Ahmad O, Rosenberg IH. Preparation and use of affinity columns with bovine milk folate binding protein (FBP) covalently linked to Sepharose 4B. Methods Enzymol 1980;66:686-90.
9. Kamen BA, Smith AK, Anderson RG. The folate receptor works in tandem with a probenecid sensitive carrier in MA104 cells in vitro. J Clin Invest 1991;87:1442-9.
10. Turek JJ, Leamon CP, Low PS. Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. J Cell Sci 1993; 106:423-30.
11. Leamon CP, Low PS. Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. Biochem J 1993;291:855-60.
12. Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 1991;88:5572-6.
13. Antony AC. The biological chemistry of folate receptors. Blood 1992;79:2807-20.
14. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994;732:432-43.
15. Shen F, Wu M, Ross JF, et al. Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity. Biochemistry 1995;34:56-60.
16. Nakashima-Matsushita N, Homma T, Yu S, et al. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1999;42;1609-16.
17. Wang G, Uludag H. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein based nanoparticles. Expert Opin Drug Deliv 2008;5:499-515.
18. Ko S, Gunasekaran S. Preparation of sub-100-nm b-lactoglobulin (BLG) nanoparticles. J Microencapsul 2006;23:887-98.
19. Peters T. Serum albumin. Adv Protein Chem 1985;37:161-245.
20. Carter DC, Ho JX. Structure of serum albumin. Adv Protein Chem 1994;45:153-203.
21. Kang RY, Freire-Moar J, Sigal E, Chu CQ. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br J Rheum 1996;35:711-18.
22. Merodio M, Arnedo A, Renedo M. Ganciclovi loaded albumin nanoparticles, characterization and in vitro release properties. Eur J Pharm Sci 2001;3:251-9.
23. Zhang L, Hou S, Mao S, et al. Uptake of folate conjugated albumin nanoparticles to the SKOV3 cells. Int J Pharm 2004;287:155-62.
24. Utreja, S, Jain NK. Solid lipid nanoparticles. In: Jain NK, ed. Advances in controlled and novel drug delivery. New Delhi: CBS Publishers and Distributors; 2001:408-24.
25. Kauper P, Rossi N, Laue C, et al. Chitosan based nanoparticles for medical applications: stability in physiological environments. Eur Cel Mat 2007;13:3-4.
26. Rodrigues AD, Halpin RA, Geer LA, et al. Absorption, metabolism, and excretion of etoricoxib: a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers. Drug Meta Dispos 2003;31: 224-32.
27. Tu J, Zhong S, Li P. Studies on acyclovir-dextran conjugate: synthesis and pharmacokinetics. Drug Dev Ind Pharm 2004;30: 959-65.
28. Winter CA, Risley E, Nuss G. Carrageenan-induced edema in hind paws of the rat as an assay for anti inflamatory drugs. Proc Soc Exp Biol Med 1962;111:544-7.